Scientist Ken Dewar from McGill University discusses his vast expertise in next-generation sequencing, some little-known facts about the launch of the 454 platform, and a revolutionary business idea for researchers running PacBio sequencers. Perhaps a solution to those dwindling grants? “There’s something fundamentally cool about this,” Dewar says.
Happy April Fools’ Day from all of us at PacBio!